SpeeDx Receives CE-IVD Mark for ResistancePlus® GC Gonorrhea Test
December 06, 2018 03:30 ET | SpeeDx Pty Ltd
SYDNEY, Australia, Dec. 06, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually transmitted...
SpeeDx broaden distribution network across Europe
November 08, 2018 04:00 ET | SpeeDx Pty Ltd
AxonLab, Diamedica, Vircell and Biomedica sign on as new distribution partners SYDNEY, Australia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- SpeeDx have announced the signing of a further four distribution...
UK drafts new M. genitalium guidelines: Resistance Guided Therapy to tackle antibiotic resistance
July 23, 2018 03:00 ET | SpeeDx Pty Ltd
LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- The British Association of Sexual Health and HIV (BASHH) draft guidelines for the sexually transmitted infection Mycoplasma genitalium (Mgen) were posted...
Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium
June 21, 2018 03:00 ET | SpeeDx Pty Ltd
SYDNEY, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced clinical data contained in a new study published in the June 2018 issue of Clinical Infectious Diseases1 [ link]...